ArticleJournal of oncology practice2015
HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals.
Article in Journal of oncology practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Comprehensive, near real-time national systemic anti-cancer therapy (SACT) data: descriptive study of implementation and applications in Scotland (UK) from 2014.ESMO real world data and digital oncology · 2026Article
- Biological Data Resources and Machine Learning Frameworks for Hematology Research.Genomics, proteomics & bioinformatics · 2025Review
- Trends in design of FDA registrational randomized clinical trials in hematology and oncology: a 20-year cohort study.BMJ connections. Oncology · 2025Article
- Summarizing clinical evidence utilizing large language models for cancer treatments: a blinded comparative analysis.Frontiers in digital health · 2025Article
- Inferring gender from first names: Comparing the accuracy of Genderize, Gender API, and the gender R package on authors of diverse nationality.PLOS digital health · 2024Article
- Introducing a Comprehensive Score of Systemic Anticancer Treatment Relevance.Studies in health technology and informatics · 2024Article
- BUILDING A DOSE TOXO-EQUIVALENCE MODEL FROM A BAYESIAN META-ANALYSIS OF PUBLISHED CLINICAL TRIALS.The annals of applied statistics · 2023Article
- An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts.International journal of radiation oncology, biology, physics · 2023Article
- Pilot study of a European oncology regimen reference library and matching algorithm.European journal of hospital pharmacy : science and practice · 2023Article
- Application of informatics in cancer research and clinical practice: Opportunities and challenges.Cancer innovation · 2022Review
- Article
- Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.JAMA network open · 2022Article
- Usage and Usability of a National e-Library for Chemotherapy Regimens: Mixed Methods Study.JMIR human factors · 2022Article
- Knowledge bases and software support for variant interpretation in precision oncology.Briefings in bioinformatics · 2021Article
- Identifying options for oncology therapy regimen codification to improve standardization-combined results of an expert panel and a review.Journal of clinical pharmacy and therapeutics · 2021Review
- Clinical comparison between trial participants and potentially eligible patients using electronic health record data: A generalizability assessment method.Journal of biomedical informatics · 2021Article
- Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study.JMIR medical informatics · 2021Article
- Artificial Intelligence Clinical Evidence Engine for Automatic Identification, Prioritization, and Extraction of Relevant Clinical Oncology Research.JCO clinical cancer informatics · 2021Article
- Chemotherapy Knowledge Base Management in the Era of Precision Oncology.JCO clinical cancer informatics · 2021Article
- Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis.Scientific reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeCancer care involves extensive knowledge about numerous chemotherapy drugs and chemotherapy regimens. This information is constantly evolving, and there has been no freely available, comprehensive, centralized repository of chemotherapy information to date.
methodsWe created an online, freely accessible, ad-free, collaborative wiki of chemotherapy information entitled HemOnc.org to address the unmet need for a central repository of this information. This Web site was developed with wiki development software and is hosted on a cloud platform. Chemotherapy drug and regimen information (including regimen variants), as well as other information of interest to hematology/oncology professionals, is housed on the site in a fully referenced and standardized format. Accredited users are allowed to freely contribute information to the site.
resultsFrom its inception in November 2011, HemOnc.org has grown rapidly and most recently has detailed information on 383 drugs and 1,298 distinct chemotherapy regimens (not counting variants) in 92 disease subtypes. There are regularly more than 2,000 visitors per week from the United States and international locations. A user evaluation demonstrated that users find the site useful, usable, and recommendable.
conclusionHemOnc.org is now the largest free source of chemotherapy drug and regimen information and is widely used. Future enhancements, including more metadata about drugs and increasingly detailed efficacy and toxicity information, will continue to improve the value of the resource.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.